Status:

RECRUITING

Research Into Factors Determining Participation in 2 Interventions Modifying the Care Pathways of Patients With Heart Failure: PRADO and Telemedicine

Lead Sponsor:

University Hospital, Montpellier

Conditions:

Heart Failure

Eligibility:

All Genders

18+ years

Brief Summary

Patients with heart failure (HF), after hospitalization, present a marked fragility. Interventions improving the coordination of care actors at the time of discharge from hospitalization have been tes...

Detailed Description

Patients with heart failure (HF), after hospitalization, present a marked fragility: in France, in the first year, 29% die and 45% are rehospitalized for HF. Interventions improving the coordination o...

Eligibility Criteria

Inclusion

  • Adult patient
  • Patient hospitalized at the time of inclusion for cardiac decompensation, or cause of admission for which heart failure plays a decisive or aggravating role (co-infection, etc.) recognized by the clinician.
  • Patient agreeing to take part in this research (absence of non-objection)

Exclusion

  • Refusal to participate
  • Pregnant or breastfeeding women, patients unable to give protected adult consent, vulnerable people (art.L.1121-6, L.1121-7, L.1211-8, L.1211-9)
  • Subject deprived of liberty by judicial or administrative decision

Key Trial Info

Start Date :

April 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2027

Estimated Enrollment :

700 Patients enrolled

Trial Details

Trial ID

NCT05417490

Start Date

April 1 2025

End Date

April 1 2027

Last Update

April 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital, Montpellier

Montpellier, France